Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 26 tags : Pharma save search
Fertility Testing Devices Market to Record 5.2% Y-O-Y Growth Rate in 2022, Evolving Opportunities with Abbott Laboratories & AdvaCare Pharma - Technavio
Published: 2022-07-26 (Crawled : 22:00) - prnewswire.com
PBH | $69.67 1.93% 0.0% 450K
|
Health Technology
|
| O: -0.34%
H: 2.81%
C: 2.25%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.26%
H: 1.16%
C: 0.56%
pharma growth market
BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial
Published: 2022-07-26 (Crawled : 20:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 8.43%
H: 0.0%
C: -22.32%
pharma children trial positive results achondroplasia
MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH
Published: 2022-07-26 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
pharma agreement international
BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia
Published: 2022-07-26 (Crawled : 13:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 8.43%
H: 0.0%
C: -22.32%
pharma trial positive results phase 2 achondroplasia
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
Published: 2022-07-26 (Crawled : 12:00) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: -0.28%
H: 0.28%
C: -6.15%
pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.